Seed and beyond. We invest in the journey.

At Tenmile, we seek to address unmet needs in human health and support the development of a globally significant health science and technology sector in Australia.

Tenmile is a dedicated health technology investment business owned by Tattarang, one of Australia’s largest private investment groups.

With an initial capital allocation of $250 million, we act fast and with confidence, investing without some of the constraints of other venture capital funds.

Focused on supporting and building early-stage companies, we have the know-how, networks and evergreen capital to partner through all stages of growth.

With team members in Perth and Sydney we seek to address unmet needs in human health and support the development of a globally significant health science and technology sector in Australia.

Tenmile-Signage

Healthcare is a global challenge requiring global solutions.

doctor-taking-notes

Building an Australian sector means understanding international markets and trends and bringing international know-how and technology to Australian patients.

We leverage extensive local and international networks to help establish and promote the companies in which we invest, connecting them to resources that will fuel their growth.

Our remit is broad, spanning all health technology and sciences with some specific areas of interest in digital health, immunology, oncology, microbial resistance and the microbiome.

If you have a good idea and a strong business case that helps solve an unmet medical need, promotes health equity or delivers affordable, sustainable healthcare, we encourage you to apply!

Fill out our investment enquiry form at the link below.

Watch this space.

Tenmile’s rapidly growing portfolio includes:

Aravax is a clinical stage biotechnology company focused on revolutionising the treatment of food allergies with next-generation specific immunotherapies which are designed to be safe, effective and convenient

VISIT SITE

Carina Biotech is an Australian pre-clinical immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies that could provide new approaches to treating solid cancers

VISIT SITE

CurveBeam AI has a unique weight bearing range of CT platforms, coupled with artificial intelligence tools to aid in diagnosis and complete surgical planning, to empower orthopaedic surgeons to manage the prevalent comorbidities of Osteoarthritis and Osteoporosis

VISIT SITE

Emyria is an innovative drug development company backed by unique and proprietary clinical evidence, focused on the development of medicinal cannabinoids and psychedelics

VISIT SITE

Inventia Life Science is advancing 3D bioprinting technology to revolutionise biomedical research and regenerative medicine.

VISIT SITE

LimmaTech Biologics AG is applying its deep expertise in engineering complex carbohydrate molecules to develop next-generation vaccines to prevent life-threatening diseases.

VISIT SITE

Mindset Health creates evidence-based digital therapeutics that use hypnotherapy to help patients manage their conditions and improve their health.

VISIT SITE

Perx is a digital care management program for medically complex members designed to deliver health and financial outcomes.

VISIT SITE

Psylo is an Australia-based biotech business focusing on next generation therapeutics inspired by psychedelic compounds in nature

VISIT SITE

Revagenix is dedicated to the discovery and development of life-changing and life-saving antimicrobials for underserved patients.

VISIT SITE

Rock Health is making healthcare massively better by investing in the next generation of entrepreneurs, advising major corporations on what matters in digital health, and working to scale health equity for all humanity

VISIT SITE

SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management

VISIT SITE

Stamford Pharmaceuticals is a clinical stage oncology focused company developing novel gene therapies focused on dermatological and visceral cancers.

VISIT SITE

Sweetch is a clinically validated platform that merges AI with behavioral science, empowering patients to better manage their chronic conditions.

VISIT SITE

Tin Alley Ventures is a University-dedicated venture capital fund that will invest in exceptional University-affiliated startups.

VISIT SITE

Verge Genomics has pioneered the industry’s most advanced all-in-human AI powered drug discovery platform.

VISIT SITE

Yosemite aims to make cancer non-lethal within our generation by supporting and funding the world’s best researchers, scientists, and entrepreneurs.

VISIT SITE

Our team is driven for your success.

Tenmile’s team of business builders, specialists and experienced investors believe in the power of health technology to improve quality of life and drive better health outcomes for all.

Its trusted advisors and domain experts are united by a quest to develop and scale a health technology and sciences sector in Australia and inspire future generations of visionary innovators.

OUR BOARD

Steve_Burnell

Dr Steve Burnell

MANAGING DIRECTOR

John_Hartman

John Hartman

DIRECTOR

Aizaz Syed
Aizaz Syed
Investment and Portfolio Manager
Arjun Balaji
Arjun Balaji
Investment Associate
JoeyMan5
Joey Man
Investment Analyst
Joe Rogers
Joe Rogers
Venture Partner
EmilyCasey
Emily Casey
Community and Partnerships Lead
Kelsee Sewell
Kelsee Sewell
Business Manager
Michael Lamprecht
Michael Lamprecht
Investment Manager
Dr Liz Dallimore
Dr Liz Dallimore
Investment Committee Member

We Are Hiring

We are committed to building a talented and passionate team. To explore Tenmile’s current vacancies, please click the link below.

News

To read all our news, including investment announcements and appointments, please explore our News stories below:

Tenmile Healthmuster02 Oct 2024Tenmile cordially invites you to our inaugural health innovation forum and celebration – The Healthtech Muster!

Carina's newest board members Michael Wyzga and Remus Vezan15 Jun 2023Carina Biotech Appoints Two New US-based Biotechnology Executives to its Board of Directors

SpeeDX Lab28 Feb 2023SpeeDx raises $26 million to accelerate new technology development and commercial expansion

Peanut20 Dec 2022Tenmile makes US$10m commitment to peanut allergy therapy

Autonomy and agility in making investment decisions is of great value. So is having access to the right partners and networks. Tenmile has both, giving our portfolio companies an extra advantage.

Being part of our family means our connections are your connections.

PARTNERS

andhealth
AusBiotech Logo_w Tagline
gates foundation
EC logo
bio101
wild

Service Partners

aws-logo
cfo-plus-logo

Our Values

Tenmile is driven by a set of values

Humility

Be vulnerable, take risks to trust others.

Courage and Determination

NEGU – we never ever give up.

Empowerment

Go to your leader for advice, not permission.

Enthusiasm

Be the most positive person in the room.

Family

Support each other, always be kind.

Frugality

Think of ways we can do things better, faster, cheaper, safer.

Generating Ideas

Always be on the lookout for breakthroughs.

Integrity

Do what you say you’re going to do.

Safety

Look out for your mates and yourself.

Stretch Targets

Always be uncomfortable with your level of challenge.

DIVERSITY

Diverse management teams make good investments. For every investment we make, we seek to understand the differential impact of a product or service by gender. We actively support female founders and encourage female participation in board and executive roles, in line with our company values.

In conjunction with Tattarang, we are thrilled to be a corporate partner in Women in Leadership Development (WiLD), a program providing Australian women in science, technology, engineering and maths (STEM) with the qualifications, skills and networks needed to attain senior leadership and board positions.

ESG

At Tenmile we not only consider the Environmental, Social and Governance (ESG) risks and opportunities associated with each investment, but we also encourage and support our investees to improve their ESG risk management and develop more sustainable business practices.

To assess overall performance of potential investees, ESG factors are considered (in addition to financial performance) at the first stage of the investment lifecycle and formally at investment decision stage. This informs our ongoing investment strategy, including active monitoring, management and reporting.

For our earliest stage companies and founders, we can offer advice on sustainability and ESG opportunities, so they are incorporated from the beginning.

Tenmile pool on the Ashburton River, in Western Australia, is a permanent and reliable source of clean water which has supported people and wildlife for millennia. A fitting name for an organisation that will support Australia’s most innovative entrepreneurs and impactful health ideas with reliable capital.

We appreciate your interest in Tenmile. If you would like to get in touch, please use the forms at the links below.

Alternatively you can:

CALL US

+61 8 6460 4949

WRITE TO US

PO Box 3155, Broadway Nedlands, WA 6009

VISIT US

171-173 Mounts Bay Road, Perth WA 6000

CONNECT ON LINKEDIN

linkedin

INVESTMENT ENQUIRIES

CAREERS